Thank you for posting this link http://www.cmleukemia.com/asco-2015---chicago.html> to the cmlhope site.

I zoomed in on the link to the article:

*Is the high cost of CML care "worth it"?
Which finished with the conclusion: ***

*Our findings showed that, despite high costs, CML care provided good value for money.
*
*

**Since 1991 when I was first diagnosed with CML a huge amount of money has been spent keeping me alive, currently it is $148 Aust per day. ($1 Aust = $0.76 US). Fortunately, we Australians, have a Universal Health Levy, which pays the major portion of this, for which myself, wife, three children and one Grandson are immensely grateful.

I would also like to acknowledge Roche Pharmaceuticals who provided me with Interferon in a clinical trial. As well as Novartis who provided me with both Glivec and Nilotinib in clinic trials.

While CML stopped me from participating in any energetic activities including sports such as tennis, I soon adjusted and found other activities which give me a pleasant life style. Most importantly, I was able to continue working until 61 years old paying Income Tax and the Medicare Health Levy which now helps to fund my medical expenses.

It is reassuring to read that people doing scientific research, also agree that money spent keeping us CMLers living longer lives, is good value for the whole community.


Regards
Robert


**


--
--
[CMLHope]
A support group of http://cmlhope.com
-------------------------------------------------

You received this message because you are subscribed to the Google Groups 
"CMLHope" group.
To post to this group, send email to [email protected]
To unsubscribe from this group, send email to 
[email protected]
For more options, visit this group at http://groups.google.com/group/CMLHope
--- You received this message because you are subscribed to the Google Groups "CMLHope" group.
To unsubscribe from this group and stop receiving emails from it, send an email 
to [email protected].
For more options, visit https://groups.google.com/d/optout.

Reply via email to